Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Industrial Chain
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
A-Share Information
H-Share Information
2023.03.30
ag真人平台官方：独立董事候选人声明（吕川）
2023.03.30
ag真人平台官方：独立董事对担保等事项的独立意见
2023.03.30
ag真人平台官方：2022年度财务决算报告
2023.03.30
2022年年度报告
2023.03.29
ag真人平台官方：深圳市ag真人平台官方药业集团股份有限公司2022年面向专业投资者公开发行公司债券2023年...
2023.03.28
ag真人平台官方：关于子公司签订许可协议的公告
2023.03.17
ag真人平台官方：关于依诺肝素钠注射液获得美国药品注册批件的公告
2023.02.24
ag真人平台官方：深圳市ag真人平台官方药业集团股份有限公司关于“20ag真人平台官方”回售结果暨摘牌公告
2023.02.24
ag真人平台官方：深圳市ag真人平台官方药业集团股份有限公司2020年面向合格投资者公开发行公司债券（疫情...
2023.01.31
ag真人平台官方：2022年度业绩预告
第一页
上一页
16
17
18
19
20
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Industrial Chain
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
